Clinical Trial Update: Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the combination of olanzapine and metoclopramide to prevent opioid-induced nausea and vomiting, currently recruiting at Affi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Nausea and Vomiting

Drugs mentioned

• Reglan (metoclopramide)
• Zyprexa (olanzapine)

Snippet

Sponsor: Affiliated Hospital of Qinghai University | Conditions: Nausea, Vomiting | Phase 3 | Status: RECRUITING